Joe Herring

Track

Insider profile

Currently holds positions in Covance Inc and Henry Schein, Inc.

Positions

Position Company Period
Chief Executive Officer Covance Inc Feb. 19, 2015 -
Independent Director Henry Schein, Inc. May 1, 2016 -
Director TeamHealth Holdings Inc Nov. 18, 2013 - May 25, 2016
Chief Executive Officer - Covance Drug Development Labcorp Holdings Inc. Feb. 19, 2015 - July 31, 2015
Chairman of the Board, Chief Executive Officer Covance Inc Jan. 1, 2006 - Feb. 19, 2015
Joe Herring's trades of Henry Schein, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
484.06
Quantity 38,198
Value US$280,972
US Covance Inc (CVD)
Transaction date
Sale
Price
188.12
Quantity 82,356 -32.5%
Value US$2,264,054
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-30
PrS Proposed sale
38,198
484.06
US$280,972 		38,198 484.06 US$280,972
2004-07-01 2004-06-30
US Covance Inc (CVD)
S Sale
82,356 -32.5%
188.12
US$2,264,054 		82,356 -32.5% 188.12 US$2,264,054